Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 93687501000001117 | Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 93687601000001118 | Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Is a | Dipyridamole+aspirin 200mg/25mg m/r capsule | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has active ingredient | Dipyridamole | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has manufactured dose form | Modified-release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has specific active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has specific active ingredient | Dipyridamole | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has dispensed dose form | Modified-release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Is a | Dipyridamole 200mg modified-release / Aspirin 25mg capsules | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) 100 capsule 2 x 50 capsules | Has AMP | False | Dipyridamole 200mg modified-release / Aspirin 25mg capsules (Mawdsley-Brooks & Company Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR